Biobank for Inflammatory Chronic Diseases and Osteoporosis
Recruiting
Observational Study
Rheumatoid Arthritis
Psoriatic Arthritis
Spondyloarthritis
Osteoporosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 99
- Sex
- Any
- Study type
- Observational
- Participants needed
- 2,000 (estimated)
- Sponsor
- University Hospital, Toulouse · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of this study is to constitute a biobank for patients followed in the Rheumatology center of Toulouse University Hospital for a chronic inflammatory rheumatism including rheumatoid arthritis (RA), spondyloarthritis(SpA), and psoriatic arthritis (PsA) or a chronic bone disease including osteoporosis in order to identify biomarkers associated with therapeutic response.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Chronic inflammatory rheumatism including RA, SpA or PsA or patients with primary or secondary osteoporosis
* With National Health Assurance
* Able to consent to the study
Exclusion Criteria:
* Pregnancy or breastfeeding
* Not able to give a consent
* Severe anemia (Hb\<10g/…
Contacts